Gentibio, Inc
Clinical trials sponsored by Gentibio, Inc, explained in plain language.
-
New cell therapy trial aims to control type 1 diabetes early
Disease control Recruiting nowThis early-stage study tests a new treatment called GNTI-122, made from a person's own blood cells, in 16 adults recently diagnosed with type 1 diabetes. The goal is to see if it is safe and how it affects the body's ability to produce insulin. Participants receive one dose and a…
Phase: PHASE1 • Sponsor: GentiBio, Inc • Aim: Disease control
Last updated May 26, 2026 04:38 UTC
-
New study maps genetic marker in recent type 1 diabetes cases
Knowledge-focused Recruiting nowThis study is for adults aged 18 to 55 who were diagnosed with type 1 diabetes within the last 6 months. Researchers want to find out how many participants have a specific genetic marker called HLA-DRB1*04:01. No treatments or medications are given—this is an observational study …
Sponsor: GentiBio, Inc • Aim: Knowledge-focused
Last updated May 22, 2026 13:53 UTC